The ibidi µ-Patterning Technology

Achieve Precise Spatial Control Over Cell Adhesion With ibidi Micropatterning

The ibidi µ-Patterning technology enables spatially defined cell adhesion for various 2D and 3D cell culture applications.

Miniaturized adhesive patterns (e.g., squares or dots) are irreversibly printed on the non-adhesive Bioinert surface of the ibidi Polymer Coverslip, allowing for precisely controlled cell adhesion. The µ-Patterns are dry-stable, sterile, and ready to use.

The µ-Pattern, the Bioinert surface, and the ibidi Polymer Coverslip are all optimized for high resolution imaging and microscopy.

ibidi's Ready-to-Use µ-Patterning Products

Application Examples

Single-Cell Arrays

The size of the µ-Pattern can be adapted to the morphology of the cell type of interest, so that an array of single cells can be conveniently analyzed using applications such as high-resolution imaging.

Single-cell array with RCC26 tumor cells. Spot size 40 µm x 40 µm. Phase contrast microscopy, 10x objective lens.

Multi-Cell Arrays

By using different geometries and sizes of the µ-Patterning, multi-cell arrays can be performed with defined adhesion for various applications, such as high-resolution imaging.

Multi-cell array with Rat1 cells. Spot size 200 µm x 200 µm. Phase contrast microscopy, 4x objective lens.

Spheroid Generation

Defined adhesion spots, surrounded by Bioinert, are able to catch all adherent single cells from a cell suspension. Bioinert is fully non-cell-attachable. This forces all cells to aggregate to each other at the adhesion spots, thus forming spheroids in a defined and controllable way.

Suspension of NIH-3T3 cell line seeded on 200 µm adhesion spots, 64 hours live cell imaging, phase contrast, 4x objective lens.

Spheroid and Organoid Culture

The size and the cell adhesion properties of the µ-Patterning can be adjusted to hold 3D spheroids and microtissues in position. Using this setup, cells in 3D can be studied during proliferation, differentiation, invasion, and migration.

Immunofluorescence staining of spheroids from RCC26 (left) and Rat1 cells (right) in in the µ-Slide VI ^0.4 Luer, patterned with 200 µm circles at 600 µm distance. The cells were stained with phalloidin (green) and alpha-tubulin (red). Nuclei were stained with DAPI (blue). Widefield fluorescence microscopy, 4x and 10x objective.

Integrating u-Patterning With the ibidi Pump System: Spheroid Culture Under Constant Media Circulation

By creating micropatterns within a µ-Slide VI ^0.4 Luer, aggregates on the pattern can be constantly supplied with fresh media by perfusing the system with the ibidi Pump System.

By applying a constant media flux around the cell aggregates, spheroids become more compact and round.

3T3 fibroblasts were seeded on a patterned µ-Slide VI ^0.4. A shear stress of 3 dyn/cm² was applied 7 days after cell seeding. 15 h time lapse microscopy, 4x objective.

CAR-T Cell Killing Assays

CAR-T cells represent a promising new cancer therapy tool. Live cell imaging allows to analyze T cell/cancer cell interaction in real time with single cell resolution. However, analysis of confluent cell layers is very time-consuming and therefore not possible in high throughput screens. To facilitate high throughput label-free analysis of T cell potency in a live cell imaging setup, we generated arrays of homogenously distributed cancer cells. By combining optical analysis and advanced image processing, cytotoxic T cell activity over time on a single cell level can be evaluated without the use of any labeling.

Single Cells in a 2D Environment

Time lapse microscopy of a CAR-T cell killing assay with RCC-26 tumor cells and JB4 T cells on a single cell pattern (µ-Slide VI ^0.4, 20 µm squares, 120 µm distance, rectangular). Data were analyzed using FastTrack AI by MetaVi Labs.

Multi-Cell Spots in a 3D Collagen Matrix

RCC-26 cancer cells immobilized on multi-cell pads (µ-Slide VI ^0.4, 200 µm circles, 600 µm distance, hexagonal). Effector T cells applied in a collagen I matrix (Collagen Type I, Rat Tail) induce apoptotic body formation of cancer cells.